A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity
| Image |  |
|---|---|
| Description | scientific article published on 10 February 2020 |
| Author/s |
author: Tomokazu Ohishi Yukinari Kato |
| Publication date | February 10, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |